1.The clonal characteristics of late recurrent hepatocellular carcinoma after resection: a study of 2 cases.
Yuyao ZHU ; Yijin GU ; Xinyuan LU ; Wenming CONG
Chinese Journal of Oncology 2014;36(6):450-452
Carcinoma, Hepatocellular
;
diagnosis
;
surgery
;
therapy
;
Hepatectomy
;
Humans
;
Liver Neoplasms
;
diagnosis
;
surgery
;
therapy
2.A Case of Combined Hepatocellular-Cholangiocarcinoma with Underlying Schistosomiasis.
Chang Kyun HONG ; Jin Mo YANG ; Bong Koo KANG ; Jin Dong KIM ; Young Chul KIM ; U Im CHANG ; Jin Young YOO
The Korean Journal of Internal Medicine 2007;22(4):283-286
Combined hepatocellular-cholangiocarcinoma is a rare form of primary liver cancer showing features of both hepatocellular and biliary epithelial differentiation. We report here on a case with collision tumor, which apparently was the coincidental occurrence of both hepatocellular carcinoma and cholangiocarcinoma underlying schistosomiasis. A 39-year-old-Philippine female was transferred to our hospital for evaluation of a liver mass that was found on ultrasonography at a local hospital. HBsAg and Anti-HCV were negative and serum alpha-fetoprotein (AFP) level was normal. The tumor mass was histologically diagnosed as adenocarcinoma by sono-guided biopsy before the operation. Partial lobectomy was performed and we histologically identified the concurrent occurrence of hepatocellular carcinoma and cholangiocarcinoma, (a "collision type carcinoma").
Adenocarcinoma/diagnosis/pathology/surgery
;
Adult
;
Carcinoma, Hepatocellular/*diagnosis/pathology/surgery
;
Cholangiocarcinoma/*diagnosis/pathology/surgery
;
Female
;
Humans
;
Schistosomiasis/*physiopathology
4.The first case of primary epithelial-myoepithelial carcinoma in the liver.
Yong LIU ; Xin-Ting SANG ; Wei-Sheng GAO ; Yi-Lei MAO ; Yue-Wu LIU ; Hong-Feng LIU ; Zhi-Ying YANG ; Song-Zhu YANG ; Shou-Xian ZHONG ; Jie-Fu HUANG
Chinese Journal of Surgery 2006;44(21):1477-1479
OBJECTIVETo report the first case of primary epithelial-myoepithelial carcinoma (EMC) in the liver.
METHODSThe clinical manifestations, imaging characteristics, and histopathological changes of EMC in this case were described. The patient was a thirty-seven-year old female. A 10 cm lesion was detected in the right liver upon a routine examination. Following that, the CT scan, magnetic resonance imaging (MRI), repeated puncture biopsies, and serum alpha-fetoprotein (AFP) detection were done with no specificity and significance found.
RESULTSRight hemi-hepatectomy was performed. The special double catheterization cannula was found in the histopathological examination, and the final diagnosis of EMC was proven by immuno-histochemical staining.
CONCLUSIONSPrimary EMC is difficult to be finally diagnosed prior to the surgery. The diagnosis can be confirmed using pathological examination and immuno-histochemical staining of the specimen.
Actins ; analysis ; Adult ; Carcinoma, Hepatocellular ; diagnosis ; metabolism ; surgery ; Female ; Hepatectomy ; methods ; Humans ; Immunohistochemistry ; Liver Neoplasms ; diagnosis ; metabolism ; surgery ; Muscle, Smooth ; chemistry ; Myoepithelioma ; diagnosis ; metabolism ; surgery ; S100 Proteins ; analysis
5.Analysis of prognostic factors in patients with hepatocellular carcinoma (≤5 cm) underwent hepatectomy.
Weiqi RONG ; Weibo YU ; Jianxiong WU ; Fan WU ; Liming WANG ; Fei TIAN ; Songlin AN ; Li FENG
Chinese Journal of Surgery 2016;54(2):89-93
OBJECTIVETo explore the clinical and pathological factors influencing the prognosis of patients with hepatocellular carcinoma (HCC)(≤5 cm) after hepatectomy.
METHODSTwo hundreds and nineteen cases with HCC(≤5 cm) undergoing hepatectomy in Cancer Hospital, Chinese Academy of Medical Sciences between December 2003 and July 2013 were collected. The alpha fetoprotein (AFP) level, tumor number, tumor size (diameter), liver cirrhosis, vascular invasion, capsular invasion, differentiation, surgical methods, resection margin, the way of treatments, the situation of recurrence and time to recurrence were analyzed. Log-rank test and the stepwise Cox proportional-hazards models were used to compare the prognosis, respectively.
RESULTSThe 1-, 3-, 5- and 10- year overall survival rates were 95.9%, 85.3%, 67.8% and 53.3% respectively in all patients.Single factor analysis indicated that vascular invasion, capsular invasion, tumor size, hepatic vascular occult, liver cirrhosis, tumor differentiation, AFP, the way of treatments, the situation of recurrence and time to recurrence can affect the prognosis significantly (all P<0.05). The multifactor analysis showed that AFP, tumor differentiation, liver cirrhosis, capsular invasion, tumor size and the situation of recurrence and time to recurrence were independent prognostic factors (all P<0.05).
CONCLUSIONThe prognosis of patients with HCC(≤5 cm) underwent hepatectomy are affected by multi-factors, such as AFP, tumor differentiation, liver cirrhosis, capsular invasion, tumor size and the situation of recurrence and time to recurrence.
Carcinoma, Hepatocellular ; diagnosis ; surgery ; Hepatectomy ; Humans ; Liver Cirrhosis ; diagnosis ; pathology ; Liver Neoplasms ; diagnosis ; surgery ; Neoplasm Recurrence, Local ; Prognosis ; Proportional Hazards Models ; Retrospective Studies ; Survival Rate ; alpha-Fetoproteins ; analysis
6.A Case of Surgical Resection in Hepatocellular Carcinoma with Pulmonary Metastasis.
Woo Jin JUNG ; Jae Young JANG ; Jun Seok PARK ; Hee Jeong LEE ; Young Kyu CHO ; Soung Won JEONG ; Sae Hwan LEE ; Sang Gyune KIM ; Sang Woo CHA ; Young Seok KIM ; Young Deok CHO ; Hong Soo KIM ; Boo Sung KIM
Journal of Liver Cancer 2016;16(2):145-150
Hepatocellular carcinoma (HCC) is well known malignancy with poor prognosis, even after resection of the primary tumor. Sorafenib is the first-line treatment in advanced HCC, but the disease control rate of sorafenib is only 43%. Pulmonary metastasectomy in patients with pulmonary metastasis from HCC has been reported to increase long-term survival compared with systemic chemotherapy. Video-assisted thoracic surgery is considered a reliable approach to the diagnosis and treatment of pulmonary diseases with low complication rate. Pulmonary metastasectomy is not universally accepted because of frequent local recurrence, an uncontrollable primary tumor, and frequent multiple pulmonary metastases in HCC, but outcome of pulmonary metastasectomy and adjuvant sorafenib therapy has not been studied. We experienced a patient who had advanced HCC with pulmonary oligometastasis and received surgical resection of the metastatic pulmonary nodule and sorafenib chemotherapy. In advanced HCC with pulmonary oligometastasis, surgical resection of pulmonary metastasis and sorafenib chemotherapy should be considered.
Carcinoma, Hepatocellular*
;
Diagnosis
;
Drug Therapy
;
Humans
;
Lung Diseases
;
Metastasectomy
;
Neoplasm Metastasis*
;
Prognosis
;
Recurrence
;
Thoracic Surgery, Video-Assisted
7.Splenosis Mimicking Hepatocellular Carcinoma.
The Korean Journal of Gastroenterology 2014;64(3):173-175
No abstract available.
Carcinoma, Hepatocellular/diagnosis
;
Diagnosis, Differential
;
Humans
;
Liver Neoplasms/diagnosis
;
Magnetic Resonance Imaging
;
Male
;
Middle Aged
;
Splenosis/*diagnosis/surgery
;
Tomography, X-Ray Computed
8.Irreversible Electroporation of a Hepatocellular Carcinoma Lesion Adjacent to a Transjugular Intrahepatic Portosystemic Shunt Stent Graft.
Christoph NIESSEN ; Ernst Michael JUNG ; Walter A WOHLGEMUTH ; Benedikt TRABOLD ; Michael HAIMERL ; Andreas SCHREYER ; Christian STROSZCZYNSKI ; Philipp WIGGERMANN
Korean Journal of Radiology 2013;14(5):797-800
We report in a 65-year-old man hepatocellular carcinoma adjacent to a transjugular intrahepatic portosystemic shunt stent-graft which was successfully treated with irreversible electroporation (IRE). IRE is a new non-thermal tissue ablation technique which uses electrical pulses to induce cell necrosis by irreversible membrane poration. IRE proved to be more advantageous in the ablation of perivascular tumor with little injury to the surrounding structures.
Aged
;
Carcinoma, Hepatocellular/diagnosis/*surgery
;
Electroporation/*methods
;
Humans
;
Liver Neoplasms/diagnosis/*surgery
;
Magnetic Resonance Imaging
;
Male
;
*Portasystemic Shunt, Transjugular Intrahepatic
;
*Stents
;
Tomography, X-Ray Computed
;
Ultrasonography, Doppler
9.The Adverse Effect of Indirectly Diagnosed Portal Hypertension on the Complications and Prognosis after Hepatic Resection of Hepatocellular Carcinoma.
Min AN ; Joong Won PARK ; Jeong A SHIN ; Joon Il CHOI ; Tae Hyun KIM ; Seong Hoon KIM ; Woo Jin LEE ; Sang Jae PARK ; Eun Kyoung HONG ; Chang Min KIM
The Korean Journal of Hepatology 2006;12(4):553-561
<0.01). The cumulative 3-year recurrence-free survival rate showed no statistical difference between the two groups. However, the cumulative 3-year survival rate was significantly higher in the non-portal hypertension group (82.8% vs. 53%, respectively, P=0.014). CONCLUSION: Indirectly diagnosed portal hypertension is correlated with the development of complications and poor prognosis after the surgical resection of HCC.
Adult
;
Aged
;
Carcinoma, Hepatocellular/complications/*surgery
;
Female
;
Humans
;
Hypertension, Portal/*diagnosis/etiology
;
Liver Neoplasms/complications/*surgery
;
Male
;
Middle Aged
;
Postoperative Complications/*diagnosis
;
Prognosis
;
Survival Rate
10.Survival analysis of patients with spontaneous rupture of hepatocellular carcinoma.
Guo-gang ZHAO ; Wei XU ; Yun-hong TIAN ; De-xin LI
Chinese Journal of Hepatology 2012;20(11):838-842
OBJECTIVETo explore the prognostic factors influencing overall survival (OS) in patients with spontaneous rupture of hepatocellular carcinoma (HCC-SR).
METHODSThe medical records of 44 patients with HCC-SR treated in our department from January 1, 2005 to April 1 2011 were retrospectively reviewed. The clinical and prognostic data of 19 HCC-SR patients who received curative hepatectomy were compared with data of 137 HCC patients with no SR who were managed by curative hepatectomy during the same period. Type of HCC-SR was defined according to previously established criteria. The clinicopathological data were evaluated for possible associations with OS of HCC-SR by univariate analysis with the Kaplan-Meier method followed by multivariate analysis with the Cox proportional hazard model.
RESULTSWhile some clinical features differed between the HCC-SR patients and non-HCC-SR patients, the postoperative prognosis was comparable between the two groups: (1) The 1-, 2-, 3- and 5-year postoperative cumulative recurrence rates were 78.9% (15/19), 89.5% (17/19), 94.7% (18/19) and 94.7% (18/19) in the HCC-SR group but 43.1% (59/137), 54.0% (74/137), 59.1% (81/137) and 66.4% (91/137) in the non-HCC-SR group respectively, and the differences reached statistical significance (P = 0.006, 0.003, 0.002, and 0.014); (2) The 1-, 2-, 3- and 5-year postoperative disease-free survival rates were 10.5% (2/19), 5.3% (1/19), 5.3% (1/19) and 5.3% (1/19) in the HCC-SR group but 40.1% (55/137), 21.2% (29/137), 12.4% (17/137) and 4.4% (6/137) in the non-HCC-SR group respectively, and only the 1-year disease-free survival rate was significantly different (P = 0.032); (3) The 1-, 2-, 3- and 5-year postoperative OS rates were 42.1% (8/19), 10.5% (2/19), 5.3% (1/19) and 5.3% (1/19) in the HCC-SR group but 59.1% (81/137), 32.8% (45/137), 19.0% (26/137) and 6.6% (9/137) in the non-HCC-SR group, and none of the differences reached statistical significance (P = 1.972, 0.061, 0.200, 1.000). Multivariate analysis identified that severity of concomitant liver cirrhosis, levels of alpha fetoprotein (AFP), choice of treatment modality, and type of HCC-SR acted as factors influencing OS.
CONCLUSIONSPatients with HCC-SR receiving curative hepatectomy have higher postoperative recurrence rates than their non-HCC-SR counterparts, but the two groups have similar postoperative OS rates. OS is influenced by severity of concomitant liver cirrhosis, level of AFP, choice of treatment modality, and type of HCC-SR.
Carcinoma, Hepatocellular ; diagnosis ; pathology ; surgery ; Female ; Hepatectomy ; Humans ; Liver Neoplasms ; diagnosis ; pathology ; surgery ; Male ; Middle Aged ; Neoplasm Recurrence, Local ; Prognosis ; Rupture, Spontaneous ; Survival Rate